Acrylic Acid

Acrylic Acid

SCHEMBL4749394

C=CC(=O)O.C=CC(=O)O.CCC(O)CO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
ALDH1A1 P00352 3/20 0.37
TSHR P16473 3/20 0.37
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
OR51E2 Q9H255 1/20 0.33
KDM4E B2RXH2 1/20 0.32
DUSP3 P51452 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
DGKA P23743 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL9562386 1.00 LMNA (0.46) LMNAALDH1A1TSHRALOX15HSD17B10
Acrylic Acid SCHEMBL28311697 0.98 LMNA (0.43) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL116158 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL3370803 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL29486376 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL25331899 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL4946329 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL733112 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL31041752 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10
Glycerin SCHEMBL29380685 0.85 LMNA (0.56) LMNAALDH1A1TSHRALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008122596-A2 CURABLE THERAPEUTIC IMPLANT COMPOSITION CINVENTION AG (DE) 2008-10-16 WO claimed
US-20080248086-A1 CURABLE THERAPEUTIC IMPLANT COMPOSITION CINVENTION AG (DE) 2008-10-09 US claimed
US-20080249638-A1 BIODEGRADABLE THERAPEUTIC IMPLANT FOR BONE OR CARTILAGE REPAIR CINVENTION AG (DE) 2008-10-09 US disclosed
US-20080248086-A1 CURABLE THERAPEUTIC IMPLANT COMPOSITION CINVENTION AG (DE) 2008-10-09 US disclosed
US-20080249637-A1 PARTIALLY BIODEGRADABLE THERAPEUTIC IMPLANT FOR BONE AND CARTILAGE REPAIR CINVENTION AG (DE) 2008-10-09 US disclosed
EP-1937753-A1 THERMOSET PARTICLES AND METHODS FOR PRODUCTION THEREOF CINVENTION AG (DE) 2008-07-02 EP disclosed
EP-1858820-A2 PROCESS FOR THE PREPARATION OF POROUS SINTERED METAL MATERIALS CINVENTION AG (DE) 2007-11-28 EP disclosed
EP-1845939-A1 DRUG DELIVERY MATERIALS MADE BY SOL/GEL TECHNOLOGY CINVENTION AG (DE) 2007-10-24 EP disclosed
WO-2007045616-A1 THERMOSET PARTICLES AND METHODS FOR PRODUCTION THEREOF CINVENTION AG (DE) 2007-04-26 WO disclosed
US-20070088114-A1 THERMOSET PARTICLES AND METHODS FOR PRODUCTION THEREOF BLUE MEMBRANES GMBH (DE) 2007-04-19 US disclosed
US-20070003749-A1 Process for production of porous reticulated composite materials CINVENTION AG (DE) 2007-01-04 US disclosed
US-20070003753-A1 Medical devices comprising a reticulated composite material CINVENTION AG (DE) 2007-01-04 US disclosed
WO-2006097503-A2 PROCESS FOR THE PREPARATION OF POROUS SINTERED METAL MATERIALS CINVENTION AG (DE) 2006-09-21 WO disclosed
US-20060211802-A1 Porous sintered metal-containing materials CINVENTION AG (DE) 2006-09-21 US disclosed
WO-2006082221-A1 DRUG DELIVERY MATERIALS MADE BY SOL/GEL TECHNOLOGY CINVENTION AG (DE) 2006-08-10 WO disclosed
US-20060171990-A1 Drug delivery materials made by sol/gel technology CINVENTION AG (DE) 2006-08-03 US disclosed
US-20060167147-A1 Metal-containing composite materials BLUE MEMBRANES GMBH 2006-07-27 US disclosed